These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10937531)

  • 41. New recommendations in diagnosis of diabetes mellitus from the Department of Health: comparing the old and new.
    Ng JM; Dawson AJ; Cox H; Atkin SL; Kilpatrick ES
    Diabet Med; 2010 Feb; 27(2):244-5. PubMed ID: 20546274
    [No Abstract]   [Full Text] [Related]  

  • 42. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemoglobin A(1c) measurement for diabetes among subjects with a previous history of impaired glucose tolerance.
    Qiao Q; Keinänen-Kukaanniemi ; Kivelä SL
    Diabetes Res Clin Pract; 1995 Dec; 30(3):189-94. PubMed ID: 8861458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The glycohaemoglobin assay as a screening test for diabetes mellitus: the Islington Diabetes Survey.
    Forrest RD; Jackson CA; Yudkin JS
    Diabet Med; 1987; 4(3):254-9. PubMed ID: 2956031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Age and sex variations of HbA(1C) in a French population without known diabetes aged 6 to 79 years].
    Gusto G; Vol S; Born C; Balkau B; Lamy J; Bourderioux C; Lantieri O; Tichet J
    Ann Biol Clin (Paris); 2011; 69(5):545-53. PubMed ID: 22008134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of casual plasma glucose levels in community screening for diabetes mellitus].
    Tsukui S; Yamaguchi Y; Kobayashi I
    Nihon Koshu Eisei Zasshi; 1997 Apr; 44(4):304-8. PubMed ID: 9212657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motherhood, apple pie, hemoglobin A(1C), and the DCCT.
    Trence DL; Hirsch IB
    Endocr Pract; 2012; 18(1):78-84. PubMed ID: 22336443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A combination of glycosylated hemoglobin and fasting plasma glucose testing facilitate screening of diabetes mellitus].
    Nunoi K
    Fukuoka Igaku Zasshi; 1984 May; 75(5):271-82. PubMed ID: 6489908
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnostic strategies to detect glucose intolerance in a multiethnic population.
    Anand SS; Razak F; Vuksan V; Gerstein HC; Malmberg K; Yi Q; Teo KK; Yusuf S
    Diabetes Care; 2003 Feb; 26(2):290-6. PubMed ID: 12547851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
    Pupillo M; De Berardis G; Antenucci D; Minnucci A; Nicolucci A
    Diabetes Res Clin Pract; 2008 Jun; 80(3):e1-3. PubMed ID: 18258329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity.
    Dubowitz N; Xue W; Long Q; Ownby JG; Olson DE; Barb D; Rhee MK; Mohan AV; Watson-Williams PI; Jackson SL; Tomolo AM; Johnson TM; Phillips LS
    Diabet Med; 2014 Aug; 31(8):927-35. PubMed ID: 24698119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population.
    Davidson MB; Schriger DL; Lorber B
    Diabetes Care; 2001 Nov; 24(11):2017-8. PubMed ID: 11679493
    [No Abstract]   [Full Text] [Related]  

  • 53. Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin.
    Fitzgerald DB; Kent BD; Garvey JF; Russell A; Nolan G; McNicholas WT
    Eur Respir J; 2012 Jul; 40(1):273-4. PubMed ID: 22753839
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia.
    Lee JM; Gebremariam A; Wu EL; LaRose J; Gurney JG
    Diabetes Care; 2011 Dec; 34(12):2597-602. PubMed ID: 21953800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of HbA(1c) in screening for Cuban-Americans with undiagnosed type 2 diabetes.
    Huffman FG; Exebio JC; Zarini GG; Exebio C
    J Immigr Minor Health; 2011 Jun; 13(3):541-5. PubMed ID: 20577810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Projected impact of implementing the results of the diabetes prevention program in the U.S. population.
    Saydah SH; Byrd-Holt D; Harris MI
    Diabetes Care; 2002 Nov; 25(11):1940-5. PubMed ID: 12401736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
    Kim KS; Kim SK; Lee YK; Park SW; Cho YW
    Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is the real contribution of fasting plasma glucose and postprandial glucose in predicting HbA(1c) and overall blood glucose control?
    Caputo S; Pitocco D; Ruotolo V; Ghirlanda G
    Diabetes Care; 2001 Nov; 24(11):2011. PubMed ID: 11679485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.